LEMME INTRODUCES BALANCE CAPSULES, A BREAKTHROUGH IN HORMONE AND OVARIAN HEALTH SUPPORT
The science-backed support for women's health arrives alongside the landmark renaming of PCOS to PMOS.
For many women, feeling "off" does not come down to a single symptom, but a pattern of changes across mood, energy, skin, and cycle health. As understanding of hormone balance continues to evolve, these shifts are increasingly recognized as connected through the body's hormonal signaling and metabolic systems. Lemme Balance is designed to support this foundation, powered by a clinically studied 40:1 ratio of Myo- and D-Chiro-Inositol, two compounds essential to ovarian function and hormone regulation. This precise ratio mirrors the body's natural balance and has been studied for its role in supporting cycle regularity and metabolic health.
"In my clinical practice, one of the biggest gaps I see is how disconnected hormone support can be from how these systems actually function in the body," says Dr.
"I hear from so many women who just want to feel like themselves again and don't always know where to start," says Lemme co-founder
Lemme Balance ($50): A daily hormone support formula featuring clinically studied Myo- and D-Chiro-Inositol in the 40:1 ratio, alongside Chromium, methylated Folate, and Spearmint to support hormone balance, ovarian health, cycle regularity, metabolic function, and overall well-being.*
Lemme Balance is available now exclusively at lemmelive.com.
Contact: [email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/lemme-introduces-balance-capsules-a-breakthrough-in-hormone-and-ovarian-health-support-302779459.html
SOURCE Lemme
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- PAINSTUDY Inc. Targets 'Self-Medication' Demand with Functional Muscle and Joint Patches
- HUTCHMED Initiates Global Trial of KRAS-EGFR-Antibody Conjugate Therapy HMPL-A830 in Patients with Solid Tumors
- Top Picks for 2026: Remittix Joins Dogecoin, TRON, Chainlink and Hyperliquid in the Growth Debate
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share